Exploring the Mechanism of Kai‐Xin‐San to Improve Cognitive Deficits in AD Rats Induced by D‐Gal and Aβ25–35 Based on Multi‐Omics and Network Analysis
Authors:
- 3 March 2025
- journal article
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (4) , e70047
Abstract
Alzheimer's disease (AD) is a common neurodegenerative disease for which there are no effective drugs. Kai‐Xin‐San (KXS), with definite curative effects, is widely used for the prevention and treatment of AD in China. But its mechanism is not yet fully understood. Based on our established rat model and previous pharmacodynamics study, Multi‐omics (metabolomics, proteomics) and network analysis were integrated to explore the holistic mechanism of anti‐AD effects of KXS. The key pathways were validated with western blot and ELISA methods. Morris water maze and Nissl staining showed that KXS could ameliorate cognitive deficits and pathological morphology of the hippocampus in AD rats. A total of nine metabolites were identified, which were related to pyrimidine metabolism, riboflavin metabolism, tyrosine metabolism, tryptophan metabolism, and glycerophospholipid metabolism. Proteomics results indicated that the improvement of cognitive deficits by KXS was closely related to the regulation of oxidative phosphorylation in mitochondria. Western blotting results showed that KXS significantly inhibited the expression of Mt‐nd2 and Ndufb6 in AD rats. Integrated analysis indicated that the anti‐AD targets of KXS were interrelated and KXS could exert its anti‐AD effect by reducing oxidative stress, neurotoxicity, and inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (82060822)
- Natural Science Foundation of Jiangxi Province (20202ACBL206030)
This publication has 47 references indexed in Scilit:
- Tandem mass tag‐based proteomics reveals the antiepileptic mechanism of steroidal saponins from Anemarrhena asphodeloides in Kainic acid induced epileptic rat modelBiomedical Chromatography, 2024
- Plasma metabolites and inflammatory proteins profiling predict outcome of Fufang Duzhong Jiangu granules treating Kashin–Beck diseaseBiomedical Chromatography, 2024
- Integrating network pharmacology and renal metabonomics to reveal the protective mechanism of resveratrol on gouty nephropathyBiomedical Chromatography, 2024
- Integration of metabolomics and network pharmacology technology to explain the effect mechanisms of Danggui Buxue decoction in vascular dementiaBiomedical Chromatography, 2024
- Glutaminase 1 isoform up-regulation associated with lipid metabolism disorder induced by methyl tertiary-butyl ether in male ratsEcotoxicology and Environmental Safety, 2023
- Biomimetic Remodeling of Microglial Riboflavin Metabolism Ameliorates Cognitive Impairment by Modulating NeuroinflammationAdvanced Science, 2023
- A metabolomic study of the urine of rats with Alzheimer's disease and the efficacy of Ding‐Zhi‐Xiao‐Wan on the afflicted ratsJournal of Separation Science, 2020
- High‐throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai‐Xin‐San against APP/PS1 transgenic mice based on UPLC–Q/TOF–MSBiomedical Chromatography, 2019
- Phosphatidylcholine protects neurons from toxic effects of amyloid β-protein in cultureBrain Research, 2016
- Mitochondrial import and degradation of amyloid-β peptideBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2014